Compared with olanzapine and aripiprazole, lurasidone was linked with lower risk for all-cause and psychiatric hospitalization in pediatric patients.
All articles by Natasha Priya Dyal, MD
Patient groups have issued a joint statement today to urge the Fifth Circuit Court of Appeals to prioritize patient protections as it presides over arguments in the case Texas v United States.
Latest News Your top articles for SaturdayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses